# A Study to Test How Well Multiple Doses of BI 765423 Are Tolerated by Healthy Men

> **NCT06232252** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 38 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 765423
- **DRUG:** Placebo matching BI 765423

## Key facts

- **NCT ID:** NCT06232252
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-06
- **Primary completion:** 2025-04-25
- **Final completion:** 2025-04-29
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06232252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06232252, "A Study to Test How Well Multiple Doses of BI 765423 Are Tolerated by Healthy Men". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06232252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*